Royal Bank of Canada’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-27,938
Closed -$106K 6534
2020
Q1
$106K Buy
27,938
+24,718
+768% +$93.8K ﹤0.01% 4261
2019
Q4
$15K Buy
3,220
+2,276
+241% +$10.6K ﹤0.01% 5400
2019
Q3
$4K Buy
944
+500
+113% +$2.12K ﹤0.01% 5497
2019
Q2
$3K Sell
444
-80
-15% -$541 ﹤0.01% 5579
2019
Q1
$2K Sell
524
-355
-40% -$1.36K ﹤0.01% 5563
2018
Q4
$3K Sell
879
-3,651
-81% -$12.5K ﹤0.01% 5505
2018
Q3
$30K Buy
4,530
+914
+25% +$6.05K ﹤0.01% 4884
2018
Q2
$30K Buy
3,616
+542
+18% +$4.5K ﹤0.01% 4798
2018
Q1
$24K Buy
3,074
+795
+35% +$6.21K ﹤0.01% 4785
2017
Q4
$14K Sell
2,279
-4,059
-64% -$24.9K ﹤0.01% 5004
2017
Q3
$47K Buy
6,338
+5,503
+659% +$40.8K ﹤0.01% 4719
2017
Q2
$6K Sell
835
-451
-35% -$3.24K ﹤0.01% 5251
2017
Q1
$13K Sell
1,286
-2,741
-68% -$27.7K ﹤0.01% 5169
2016
Q4
$35K Buy
+4,027
New +$35K ﹤0.01% 4718
2016
Q3
Sell
-438
Closed -$1K 5793
2016
Q2
$1K Sell
438
-629
-59% -$1.44K ﹤0.01% 5574
2016
Q1
$5K Sell
1,067
-9,901
-90% -$46.4K ﹤0.01% 5226
2015
Q4
$67K Sell
10,968
-27,719
-72% -$169K ﹤0.01% 4451
2015
Q3
$221K Buy
38,687
+38,652
+110,434% +$221K ﹤0.01% 3677
2015
Q2
$0 Sell
35
-265
-88% ﹤0.01% 6199
2015
Q1
$2K Sell
300
-450
-60% -$3K ﹤0.01% 5469
2014
Q4
$6K Buy
750
+450
+150% +$3.6K ﹤0.01% 5176
2014
Q3
$2K Sell
300
-55
-15% -$367 ﹤0.01% 5251
2014
Q2
$1K Buy
355
+55
+18% +$155 ﹤0.01% 5327
2014
Q1
$1K Hold
300
﹤0.01% 5261
2013
Q4
$2K Sell
300
-827
-73% -$5.51K ﹤0.01% 5129
2013
Q3
$6K Buy
1,127
+827
+276% +$4.4K ﹤0.01% 5018
2013
Q2
$1K Buy
+300
New +$1K ﹤0.01% 5140